Evommune Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Evommune Inc had 60.03M in cash and cash equivalents.

Evommune Inc reported 19.38M in total liabilities as of the latest reported quarter, including 17.91M in current liabilities and 1.47M in non-current liabilities.

As of the latest reported quarter, Evommune Inc's total assets were 224.95M, consisting of 153.48M in current assets and 71.47M in non-current assets.

Evommune Inc reported 205.57M in total shareholders' equity as of the latest reported quarter.